GLW
48
-5
MU
32
-6
STX
52
-4
LEN
52
2
NOV
58
-2
WMB
68
-2
BK
72
-2
CSX
68
3
EXR
59
4
FLR
48
3
LRCX
46
-2
XEL
65
-2
GOOGL
59
-8
PLD
56
8
PWR
71
-3
DE
36
-2
NWS
79
-4
EMN
50
-2
FTI
78
-3
BAX
27
-2
GLW
48
-5
MU
32
-6
STX
52
-4
LEN
52
2
NOV
58
-2
WMB
68
-2
BK
72
-2
CSX
68
3
EXR
59
4
FLR
48
3
LRCX
46
-2
XEL
65
-2
GOOGL
59
-8
PLD
56
8
PWR
71
-3
DE
36
-2
NWS
79
-4
EMN
50
-2
FTI
78
-3
BAX
27
-2
Financhill
Back

Liquidia Vs. Arcturus Therapeutics Holdings Industry Stock Comparison

Sell
45

LQDA
Liquidia

Last Price:
10.04
Seasonality Move:
33.94%
Sell
32

ARCT
Arcturus Therapeutics Holdings

Last Price:
18.32
Seasonality Move:
4.49%
Sell
45
Liquidia (LQDA) is a Sell

Is Liquidia a Buy, Sell or Hold?

  • The current Liquidia [LQDA] share price is $10.27. The Score for LQDA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • LQDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $19.18. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LQDA Stock Price Chart

What is Liquidia's stock price today?

  • The Liquidia share price today is $10.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LQDA is experiencing selling pressure, which indicates risk of future bearish movement.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $19.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.

LQDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39.99 Sell
Chaikin Money Flow: -815167 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.67 - 11.25) Sell
Bollinger Bands (100): (9.85 - 12.09) Sell

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: -240644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.46 - 20.82) Sell
Bollinger Bands (100): (19.25 - 23.41) Sell

LQDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.63 Sell
20-day SMA: 10.91 Sell
50-day SMA: 10.43 Sell
200-day SMA: 12.41 Sell
8-day EMA: 10.66 Sell
20-day EMA: 10.76 Sell
50-day EMA: 10.76 Sell
200-day EMA: 11.14 Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.99 Buy
20-day SMA: 19.26 Sell
50-day SMA: 20.58 Sell
200-day SMA: 27.29 Sell
8-day EMA: 19.22 Sell
20-day EMA: 19.5 Sell
50-day EMA: 20.49 Sell
200-day EMA: 24.49 Sell

Liquidia Earnings Growth & LQDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $0.39 per share.

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.97 per share.

Liquidia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):